BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bae JS, Kim JH, Joo I, Chang W, Han JK. MDCT findings predicting post-operative residual tumor and survival in patients with pancreatic cancer. Eur Radiol 2019;29:3714-24. [PMID: 30899975 DOI: 10.1007/s00330-019-06140-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Oshi M, Newman S, Tokumaru Y, Yan L, Matsuyama R, Endo I, Katz MHG, Takabe K. High G2M Pathway Score Pancreatic Cancer is Associated with Worse Survival, Particularly after Margin-Positive (R1 or R2) Resection. Cancers (Basel) 2020;12:E2871. [PMID: 33036243 DOI: 10.3390/cancers12102871] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
2 Grogan A, Loveday B, Michael M, Wong HL, Gibbs P, Thomson B, Lee B, Ko HS. Real-world staging computed tomography scanning technique and important reporting discrepancies in pancreatic ductal adenocarcinoma. ANZ J Surg 2022. [PMID: 35614381 DOI: 10.1111/ans.17787] [Reference Citation Analysis]
3 Ishido K, Hakamada K, Kimura N, Miura T, Wakiya T. Essential updates 2018/2019: Current topics in the surgical treatment of pancreatic ductal adenocarcinoma. Ann Gastroenterol Surg 2021;5:7-23. [PMID: 33532676 DOI: 10.1002/ags3.12379] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bae JS, Kim JH, Kang HJ, Han JK. Prediction of residual tumor and overall survival after first-line surgery in patients with pancreatic ductal adenocarcinoma using preoperative magnetic resonance imaging findings. Acta Radiol 2022;63:435-46. [PMID: 33682455 DOI: 10.1177/0284185121999998] [Reference Citation Analysis]
5 Toshima F, Inoue D, Yoshida K, Izumozaki A, Yoneda N, Minehiro K, Gabata T. CT-diagnosed extra-pancreatic extension of pancreatic ductal adenocarcinoma is a more reliable prognostic factor for survival than pathology-diagnosed extension. Eur Radiol 2021. [PMID: 34263360 DOI: 10.1007/s00330-021-08180-6] [Reference Citation Analysis]
6 Chen X, Liu F, Xue Q, Weng X, Xu F. Metastatic pancreatic cancer: Mechanisms and detection (Review). Oncol Rep 2021;46:231. [PMID: 34498718 DOI: 10.3892/or.2021.8182] [Reference Citation Analysis]
7 Katsuta E, Rashid OM, Takabe K. Fibroblasts as a Biological Marker for Curative Resection in Pancreatic Ductal Adenocarcinoma. Int J Mol Sci 2020;21:E3890. [PMID: 32485981 DOI: 10.3390/ijms21113890] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
8 Wen G, Gu J, Zhou W, Wang L, Tian Y, Dong Y, Fu L, Wu H. Benefits of 18F-FDG PET/CT for the preoperative characterisation or staging of disease in the ampullary and duodenal papillary. Eur Radiol 2020;30:5089-98. [PMID: 32346795 DOI: 10.1007/s00330-020-06864-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Safi SA, Haeberle L, Heuveldop S, Kroepil P, Fung S, Rehders A, Keitel V, Luedde T, Fuerst G, Esposito I, Ziayee F, Antoch G, Knoefel WT, Fluegen G. Pre-Operative MDCT Staging Predicts Mesopancreatic Fat Infiltration-A Novel Marker for Neoadjuvant Treatment? Cancers (Basel) 2021;13:4361. [PMID: 34503170 DOI: 10.3390/cancers13174361] [Reference Citation Analysis]
10 Nagakawa Y, Nakagawa N, Takishita C, Uyama I, Kozono S, Osakabe H, Suzuki K, Nakagawa N, Hosokawa Y, Shirota T, Honda M, Yamada T, Katsumata K, Tsuchida A. Reconsideration of the Appropriate Dissection Range Based on Japanese Anatomical Classification for Resectable Pancreatic Head Cancer in the Era of Multimodal Treatment. Cancers (Basel) 2021;13:3605. [PMID: 34298818 DOI: 10.3390/cancers13143605] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Yoo J, Kim JH, Bae JS, Kang HJ. Prediction of prognosis and resectability using MR imaging, clinical, and histopathological findings in patients with perihilar cholangiocarcinoma. Abdom Radiol (NY) 2021;46:4159-69. [PMID: 33929600 DOI: 10.1007/s00261-021-03101-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Cai X, Gao F, Qi Y, Lan G, Zhang X, Ji R, Xu Y, Liu C, Shi Y. Pancreatic adenocarcinoma: quantitative CT features are correlated with fibrous stromal fraction and help predict outcome after resection. Eur Radiol 2020;30:5158-69. [PMID: 32346792 DOI: 10.1007/s00330-020-06853-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]